PDE9A Antikörper (N-Term)
Kurzübersicht für PDE9A Antikörper (N-Term) (ABIN630634)
Target
Alle PDE9A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- PDE9 A antibody was raised against the N terminal of PDE9
-
Aufreinigung
- Affinity purified
-
Immunogen
- PDE9 A antibody was raised using the N terminal of PDE9 corresponding to a region with amino acids SDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPET
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
PDE9A Blocking Peptide, (ABIN5615280), is also available for use as a blocking control in assays to test for specificity of this PDE9A antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PDE0 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PDE9A (phosphodiesterase 9A (PDE9A))
-
Andere Bezeichnung
- PDE9A
-
Hintergrund
- PDE9A catalyzes the hydrolysis of cAMP and cGMP to their corresponding monophosphates. The protein plays a role in signal transduction by regulating the intracellular concentration of these cyclic nucleotides.
-
Molekulargewicht
- 61 kDa (MW of target protein)
Target
-